Your browser doesn't support javascript.
loading
The "Lightbulb" Sign: A Novel Echocardiographic Finding Using Ultrasound Enhancing Agent in Fulminant COVID-19-Related Myocarditis.
Nanthakumar, Ayana; Worme, Mali; Rahman, Tahseen; Alvarez, Juglans; Doufle, Ghislaine; Tsang, Wendy; Nesbitt, Gillian; Mulvagh, Sharon L.
Afiliação
  • Nanthakumar A; Division of Cardiology, University Health Network, Toronto, Ontario, Canada.
  • Worme M; Division of Cardiology, University Health Network, Toronto, Ontario, Canada.
  • Rahman T; Division of Cardiology, Trillium Health Partners, Mississauga, Ontario, Canada.
  • Alvarez J; Division of Cardiothoracic Surgery, University Health Network, Toronto, Ontario, Canada.
  • Doufle G; Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Tsang W; Department of Anesthesia and Pain Management, University Health Network, Toronto, Ontario, Canada.
  • Nesbitt G; Division of Cardiology, University Health Network, Toronto, Ontario, Canada.
  • Mulvagh SL; Division of Cardiology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
JACC Case Rep ; 28: 102120, 2023 Dec 20.
Article em En | MEDLINE | ID: mdl-38204556
ABSTRACT
We report a case of fulminant COVID-19-related myocarditis requiring venoarterial extracorporeal membrane oxygenation where the use of an ultrasound-enhancing agent demonstrated a previously undescribed echocardiographic finding, the "lightbulb" sign. This sign potentially represents a new area for the use of an ultrasound enhancing agent in the echocardiographic diagnosis of myocarditis.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article